Bicycle Therapeutics

Bicycle Therapeutics is an England-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer and inflammatory diseases.

Business Model:

Revenue: $15M

Employees: 51-200

Detailed Bicycle Therapeutics Information

Geographic Data

Bicycle Therapeutics headquarters map

Address: B900, Babraham Research Campus

City: Cambridge

State: england

Zip: CB22 3AT

Country: GB

Financial Info

Stage:

post ipo equity

Raised Last:

$175M

Raised Total:

$343M

Metrics

3,099,739Website Global Rank

5,402Website Monthly Traffic

Twitter Followers

Description

Bicycle Therapeutics is an England-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer and inflammatory diseases.

Contact Phone:

Contact Email:

Bicycle Therapeutics went public on 5/23/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/23/2019

IPO Valuation:
$248M

Ticker Symbol:
BCYC

IPO Price:
$14/share

Amount Raised:
$61M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2012 Venture Round 5 $6M SV Health Investors
SR One
Novartis Venture Fund
Atlas Venture
Astellas Venture Management
10/2014 Series A 6 $32M Syndicate
SV Health Investors
SR One
Novartis Venture Fund
Atlas Venture
Astellas Venture Management
10/2009 Seed Round 2 - Novartis Venture Fund
Atlas Venture
Novartis Venture Fund
Atlas Venture
6/2017 Series B 9 $52M Ahren Innovation Capital
Longwood Fund
Cambridge Innovation Capital
Vertex Ventures HC
SR One
Vertex Ventures
SV Health Investors
Novartis Venture Fund
Atlas Venture
Ahren Innovation Capital
Longwood Fund
Cambridge Innovation Capital
Vertex Ventures HC
SR One
Vertex Ventures
3/2008 Grant 1 $9.7k Venture Kick
Venture Kick
10/2020 Debt Financing 1 $50M Hercules Capital
Hercules Capital
4/2010 Seed Round 2 - SV Health Investors
SR One
SV Health Investors
SR One
9/2020 Post-IPO Debt -
9/2020 Private Placement $50M
10/2021 Post-IPO Equity $201.3M
5/2019 IPO $60.7M
10/2021 Post-IPO Equity $175M
1/2018 Grant 1 - Innovate UK
Innovate UK
Innovate UK
Innovate UK
10/2016 Series A 2 - SV Health Investors
SR One
SV Health Investors
SR One
12/2018 Series B 3 $27.9M Vertex Ventures
Cambridge Innovation Capital
Tybourne Capital Management
Vertex Ventures
Cambridge Innovation Capital
Tybourne Capital Management
5/2017 Series B $51.4M Cambridge Innovation Capital
Vertex Ventures HC
Longwood Fund
Novartis Venture Fund
S.V. Life Sciences
S.R. One
Atlas Venture
3/2016 Series A 1 - SV Health Investors
SV Health Investors
9/2020 Post-IPO Debt -
1/2018 Grant 1 - Innovate UK
Innovate UK
Innovate UK
Innovate UK
10/2016 Series A 2 -
3/2016 Series A 1 -
4/2010 Seed Round 2 -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research